Ingredients:  Tri-Amino 300mg (Compounded) contains;

  • L-Ornithine 100mg/mL
  • L-Arginine 100mg/mL
  • L-Citrulline 100mg /mL

How supplied: Tri-Amino is available in 10ml and 30ml sterile glass bottles.

How to Administer Tri-Amino: Tri-Amino must be administered by injection using a small gauge needle.  There are a few different ways to administer Tri-Amino, depending on the goal.  Be sure to rotate injection sites. 

  • Optimize health, improve circulation, and increase HGH & NO:  Using a 1ml “insulin” syringe with 31g needle, inject 1mL of Tri-Amino subcutaneously before bedtime.
  • Increase performance, strength, endurance, and recovery: Using a 3ml 25g 5/8” syringe, inject 1.5-3mL of Tri-Amino into the gluteus (butt), shoulder, thigh 30-60min prior to exercise (or 3-4 times per week).   
  • Optimal Performance: For 30 days:  inject 1mL subcutaneously every evening before bed time.   inject another  1.5-3mL of Tri-Amino into the gluteus (butt), shoulder, thigh 30-60min prior to exercise (or 3-4 times per week).  
  • Intravenous Infusion: Tri-Amino can be directly infused into the vein by a trained medical professional. 

Summary: Tri-Amino is a compounded injectable nutrient which contains the three amino-acids L-Ornithine, L-Arginine, and L-Citrulline.  Each milliliter (mL) of solution contains 100mg of each amino, totaling 300mg per mL. These specific amino-acids are combined to promote the production of nitric oxide, an important chemical which is involved in many of our biological functions.  Tri-Amino also supports healthy levels of Human Growth Hormone (GH) by stimulating the release of GH from the pituitary gland.  Tri-Amino is designed to help improve lean body mass, athletic performance, cardiovascular health, and vascular function.  It is also used to promote wound healing and recovery from sports-related (or work) injury.

Side Effects:  Possible side effects include abdominal pain and bloating, and diarrhea.  Tri-Amino may interact with certain medications that lower blood pressure. It may also interact with certain heart medications and drugs such as Viagra that treat erectile dysfunction.  Please let your physician know if you are taking any blood pressure medications or are being treated for blood pressure.  Irritation from the injection may occur and may include redness, swelling, and pain.  This usually resides within a couple days after the injection.  Please speak to your physician if you are experiencing any side effects after taking Tri-Amino. 

Overview of Effects

  • Enhances the release of Human Growth Hormone
  • Increases the synthesis of nitric oxide (NO)
  • Antioxidant effects (2)
  • Reduces exercise-induced accumulation of plasma lactate and ammonia (3)
  • Increases vasodilation
  • Decreases blood pressure (4)
  • Promotes wound healing
  • Improves kidney function and disease
  • Increases protein synthesis
  • Improves erectile function and cardiovascular health 

Healing Injuries:  L-Arginine and nitric oxide (NO) have significant effects on muscle metabolism and recovery.  NO has beneficial effects on collagen synthesis and wound healing.  NO has also been shown to enhance tendon healing (5-7). 

Nitric Oxide (NO):   In mammals including humans, NO is an important cellular signaling molecule involved in many physiological and pathological processes.[1] It is a powerful vasodilator with a short half-life of a few seconds in the blood. Research over the last three decades has shown that arginine’s main influence on metabolism and health is via Nitric Oxide production (8-10).  L-Arginine remains the largest source of nitrogen in the body for NO production, its relevance and metabolism of NO has received much attention over the last decade.  Nitric Oxide functions as: a Regulator of healthy blood pressure; a killer of bacteria and tumor cells; a messenger molecule to the brain involved in memory and thought process (11); a regulator of inflammation and the immune system (12); and many other important processes in the body.  Supplementation with L-citrulline may increase the body’s production of nitric oxide (NO) more effectively than L-arginine.

Athletic Performance: Studies show that a combination of Arginine, Citrulline, and Ornithine (Tri-Amino) has been shown to increase exercise performance (13).  L-Arginine has several important metabolic and biological effects, which include improving vascular function, being a substrate in the synthesis of creatine, and the ability to stimulate insulin, glucagon, catecholamines, and GH secretion, leading to anabolic and anti-catabolic effects on skeletal muscle.   Both L-Arginine and L-Ornithine decrease muscle fatigue during exercise by reducing exercise-induced accumulation of lactate and ammonia, which allows the muscle to perform for longer periods.  In addition, recovery time is significantly decreased after exercise and training. 

Food and Energy Metabolism:  Studies have shown that L-Arginine influences macronutrient metabolism (14-15)

Sexual Function and Cardiovascular Health: Increasing systemic levels of L-arginine has been demonstrated to significantly improve endothelial function in individuals with essential hypertension, compromised flow-mediated dilation, arterial stiffness, chronic heart failure, impaired glucose tolerance (MetS) and type 2 diabetes – all of which are common concomitant medical conditions associated with Erectile Dysfunction (ED).   Supplementing ED patients with L-citrulline can provide systemic as well as sexual performance benefits.

References: 

  1. A: Roszer, T (2012) The Biology of Subcellular Nitric Oxide. ISBN 978-94-007-2818-9 B:  Weller, Richard, Could the sun be good for your heart? TedxGlasgow March 2012, posted January 2013
  2. Lin, W.T., Yang, S.C., Chen, K.T., Huang, C.C., and Lee, N.Y., Protective effects of L-Arginine on pulmonary oxidative stress and antioxidant defences during exhaustive exercise in rats, Acta Pharmacol. Sin, 26(8), 992, 2005.
  3. Schaefer, A., Piquard, F., Geny, B., Doutreleau, S., Lampert, E., Mettauer, B., and Lonsdorfer, J., L-arginine reduces exercise-induced increase on plasma lactate and ammonia, Int. J. Sports Med., 23(6) 403-407, 2002
  4. Gokce, N., L-arginine and hypertention, J. Nutr., 134(10 Suppl), 2807S-2811S, 2004
  5. Murrell, G.A., Szabo, C., Hannafin, J.A., et al., Modulation of tendon healing by nitric oxide, Inflamm. Res., 46, 19-27, 1997.
  6. Lin, J.H., Wang, M.X. Wei, A.Q., et al., Temporal expression of nitric oxide synthase isoforms in healing Achilles tendon, J. Orthop. Res., 19, 136-142, 2001.
  7. Lin, J.H., Wang, M.X. Wei, A.Q., et al., The cell specific temporal expression of nitric oxide synthase isoforms during Achilles tendon healing, Inflamm. Res., 50, 515-522, 2001.
  8. Berdeaux, A., Nitric oxide: An ubiquitius messenger, Fund. Clin. Pharmacol., 7(8), 401-411, 1993.
  9. Morikawa, E., Huang, Z., and Moskowitz, M.A., L-arginine decreases infarct size caused by middle cerebral arterial occlusion in SHR, Am, J. Physiol., 263(5, Pt2), H1632-H1635, 1992.
  10. Huynh, N.N., and Chin-Dusting, J., Amino acids, arginase and nitric oxide in vascular health, Clin. Exp. Pharmacol. Physiol., 33 (1-2), 1-8, 2006.
  11. Marin, J., and Govantes, C., Angiotensin-converting enzyme inhibitors and the role of nitric oxide and excitatory amino acids in improvement of cognition and memory, J. Autonom. Pharmacol., 15(2), 129-149, 1995
  12. Albina, J.E. and Reichner, J.S., Nitric Oxide in inflammation and immunity, New Horizons, 3(1), 46-64, 1995
  13. Meneguallo, M.O., Mendonca, J.R., Lancha, A.H., Jr., and Costa Rosa, L.F., Effect of arginine, ornithine, and citrulline supplementation upon performance and metabolism of trained rats, Cell. Biochem. Funct. 21(1), 85-91, 2003. 
  14. Beaumier, L., Castillo, L., Yu., Y.M., Ajami, A.M., and Young, V.R., Arginine: New and exciting developments for an “old” amino acid, Biochem. Environ. Sci. 9(2-3), 296-315, 1996.
  15. McConell, G.K., Huynh, N.N., Lee-Young, R.S., Canny, B.J., and Wadley, G.D., L-arginine infusion increases glucose clearance during prolonged exercise in humans, Am. J. Physiol. Endocrinol. Metab., 290(1), E60-E66, 2006.
Share